Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05072639
Other study ID # 15989
Secondary ID NCI-2021-10906
Status Completed
Phase N/A
First received
Last updated
Start date March 25, 2017
Est. completion date September 30, 2019

Study information

Verified date October 2021
Source University of California, San Francisco
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a prospective randomized controlled trial of patients undergoing major urologic-oncologic surgery at the University of California, San Francisco (UCSF) Medical Center and the Helen Diller Family Comprehensive Cancer Center. This clinical trial examines the effect of guided meditation before surgery on the levels of anxiety, stress, sleep disturbance, and quality of life among patients scheduled to undergo a major urologic surgery for cancer. A cancer diagnosis and the treatments associated with it can be very stressful for patients, leading to depression, sleep disturbances, and lower quality of life. Mind-body practices such as guided meditation have been used for thousands of years to reduce the effects of chronic stress and to improve quality of life. This clinical trial examines the effects of guided meditation on the stress, depression, and quality of life levels of patients undergoing urologic surgery for their cancer.


Description:

PRIMARY OBJECTIVE: I. To determine the effect of 14 days of preoperative guided visualization meditation on patients' anxiety undergoing major urologic-oncology surgery. SECONDARY OBJECTIVES: I. To determine the effect of preoperative guided visualization meditation on patients' depression, stress, and quality of life. II. To examine the difference in Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Survey question scores between the two study groups. III. To determine the ability of patient to perform a daily 23 minute meditation. IV. To examine the correlation between depression and emergency department (ED) visits and readmissions post-operations. OUTLINE: Patients are randomized to 1 of 2 arms. ARM 1: Patients listen to guided meditation over 23 minutes daily for two weeks before their standard of care surgery. Patients also complete surveys over 10-15 minutes at baseline, after 10 days, 1 day before standard of care surgery, the day after discharge, and then 4 weeks after surgery. ARM 2: Patients complete surveys over 10-15 minutes at baseline, after 10 days, 1 day before standard of care surgery, the day after discharge, and then 4 weeks after surgery.


Recruitment information / eligibility

Status Completed
Enrollment 123
Est. completion date September 30, 2019
Est. primary completion date September 30, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Greater than or equal to 18 years of age. - Patients undergoing radical cystectomy, radical or partial nephrectomy, or radical prostatectomy at the University of California, San Francisco (UCSF) Medical Center and the Helen Diller Family Comprehensive Cancer Center - Access to an electronic device that can play mp3 recording and for survey completion - At least a 2 week window from date of surgical booking to the scheduled surgery Exclusion Criteria: - Inability to consent for the study (ie, they have a surrogate decision maker). - Non-English speaker (the meditations are only available in English) - Patients scheduled for surgery less than 2 weeks away

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Guided Meditation
23 minute audio recording

Locations

Country Name City State
United States University of California, San Francisco San Francisco California

Sponsors (1)

Lead Sponsor Collaborator
University of California, San Francisco

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in scores on the State-Trait Anxiety Inventory (STAI) from baseline to day before surgery The Spielberger et. al STAI is a commonly used measure of trait and state anxiety . It can be used in clinical settings to diagnose anxiety and to distinguish it from depressive syndromes. It has 20 items for assessing trait anxiety and 20 for state anxiety for a total of 40 items. State anxiety items include: "I am tense; I am worried" and "I feel calm; I feel secure." Trait anxiety items include: "I worry too much over something that really doesn't matter" and "I am content; I am a steady person." All items are rated on a 4-point scale (e.g., from "1=Almost Never" to 4="Almost Always") with a maximum score range of 40-160 when all 40 items are administered Higher scores indicate greater anxiety. A two sample t-test will be used to compare the change between anxiety scores from baseline to the time point the day before surgery for the population as a whole and then adjusted for by surgery type. Up to 4 weeks
Secondary Change in scores on the State-Trait Anxiety Inventory (STAI) over time The Spielberger et. al STAI is a commonly used measure of trait and state anxiety . It can be used in clinical settings to diagnose anxiety and to distinguish it from depressive syndromes. It has 20 items for assessing trait anxiety and 20 for state anxiety for a total of 40 items. State anxiety items include: "I am tense; I am worried" and "I feel calm; I feel secure." Trait anxiety items include: "I worry too much over something that really doesn't matter" and "I am content; I am a steady person." All items are rated on a 4-point scale (e.g., from "1=Almost Never" to 4="Almost Always") with a maximum score range of 40-160 when all 40 items are administered Higher scores indicate greater anxiety. Up to 6 months
Secondary Change in scores on the Center for Epidemiologic Depression Scale (CESD) over time The Center for Epidemiological Studies-Depression (CESD) is a 20-item measure that asks caregivers to rate how often over the past week participants experienced symptoms associated with depression, such as restless sleep, poor appetite, and feeling lonely. Response options range from 0 to 3 for each item (0 = Rarely or None of the Time, 1 = Some or Little of the Time, 2 = Moderately or Much of the time, 3 = Most or Almost All the Time). Scores range from 0 to 60, with high scores indicating greater depressive symptoms. Up to 6 months
Secondary Change in scores on the Perceived Stress Scale (PSS) over time The PSS is a 10-item questionnaire which asks participants about feelings and thoughts during the last month. In each case, respondents are asked how often participants felt a certain way. Scores of each item ranging from 0 = "Never" to 4 = "Very Often" for a total score range of 0 to 40. Scores are obtained by reversing responses (e.g., 0 = 4, 1 = 3, 2 = 2, 3 = 1 & 4 = 0) to 4 of the 10 positively stated items and scores are calculated by summing the total. Higher scores indicate higher degree of perceived stress. Up to 6 months
Secondary Change in scores on the National Comprehensive Cancer Network (NCCN) Distress Thermometer over time The NCCN Distress Thermometer is a single item screening tool among cancer care providers. which measures distress by asking participants to report their level of distress in the past week on a 0 to 10 scale, with a score of 0='No distress' and 10='Extreme Distress'. Up to 6 months
Secondary Change in scores on the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) for cancer patients (EORTC-QLQ-C30) - Functional Domains over time The functional domains measure the quality of life in Physical functioning, Role functioning, Emotional functioning, Cognitive functioning, Social functioning. Scores consists of responses to items with responses ranging from 1="Not at all" to 4="Very Much". The raw score is calculated by estimating the mean of the items that make up each domains with a resulting total range of 1 - 4. These scores are then transformed to standardized scale score, so that scores range from 0 to 100. A high score for the functional domains represents a high level of functioning Up to 6 months
Secondary Change in scores on the EORTC-QLQ-C30 Global Health Status over time The global health status score consists of responses to two items with responses ranging from 1="very poor" to 4="excellent". The raw score is calculated by estimating the mean of the two items that make up the global health scale with a resulting total range of 1-7. These scores are then transformed to standardized scale score, so that scores range from 0 to 100. A high score for the global health status represents a higher quality of life. Up to 6 months
Secondary Change in scores on the EORTC-QLQ-C30 - Symptoms over time The Pain score consists of responses to two items with responses ranging from 1="Not at all" to 4="Very Much". The raw score is calculated by estimating the mean of the two items that make up the pain scale with a resulting total range of 1-4. These scores are then transformed to standardized scale score, so that scores range from 0 to 100. A high score for the pain scale / item represents a high level of symptomatology / problems. Up to 6 months
Secondary Mean scores on the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Survey HCAHPS is a 29-item survey for measuring patients' perceptions of their hospital experience. The questions address participants recent hospital stay and contain 19 core questions about critical aspects of patients' hospital experiences (communication with nurses and doctors, the responsiveness of hospital staff, the cleanliness and quietness of the hospital environment, communication about medicines, discharge information, overall rating of hospital, and would patients recommend the hospital). The survey also includes 3 items to direct patients to relevant questions, five items to adjust for the mix of patients across hospitals, and 2 items that support Congressionally-mandated reports. Total scores are calculated by summing the items in each domain with higher scores indicating a greater overall satisfaction. A comparison of mean scores of HCAHPS survey questions between the two study groups using a two sample t-test. Up to 6 months
Secondary Proportion of participants who completed daily meditation Participants in the intervention arm will receive an automated text message once a week before their surgery to remind them of the daily meditation routine. Participants will then be asked to report how many days of completed meditations have been completed in the past week. Up to 6 months
Secondary Percentage of emergency department (ED) visits at 4 weeks post-operative The percentage of participants who visited the emergency department for an oncological related event within 4 weeks post surgery will be reported. 4 weeks
Secondary Rates of hospital re-admission rates at 4 weeks post operatively The percentage of participants who were re-admitted to the hospital for an oncological related event within 4 weeks post surgery will be reported. 4 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT06397287 - PROM Project Urology
Active, not recruiting NCT04840511 - The Effect of Perioperative Lidocaine Infusion on Neutrophil Extracellular Trapping N/A
Not yet recruiting NCT06398314 - Palliative Radiotherapy in Symptomatic Pelvic Soft Tissue Tumors N/A
Completed NCT04933604 - LPN in Patients With High-complex Renal Tumors
Recruiting NCT06187870 - Bank of Biological Material From Patients and Healthy Donors for the Study of Urological and Uro-oncological Pathologies
Recruiting NCT05726136 - Fluid Challenge and Plasma Volume, During Surgery Phase 4
Not yet recruiting NCT03715855 - Demonstrating the Diagnostic Power of an Electronic Nose: Study on Exhaled Air Samples N/A
Recruiting NCT04931979 - SRT in Combination With Pembrolizumab in Patients With Recurrent Prostate Cancer After Radical Prostatectomy Phase 2
Terminated NCT03721042 - Demonstrating the Diagnostic Power of an Electronic Nose: Study on Exhaled Air Samples N/A
Recruiting NCT05913245 - Preoperative Carbohydrate Loading for Enhancing Recovery After Radical Cystectomy N/A
Active, not recruiting NCT05169437 - Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors Phase 2
Completed NCT04213157 - Laparoscopic Partial Nephrectomy for cT1 Tumors
Not yet recruiting NCT06282354 - Telemedicine for Postoperative Follow-up After Oncological Surgeries
Completed NCT04720599 - Clinical Evaluation of ExoDx Prostate(IntelliScore) in Men Presenting for Initial Prostate Biopsy
Recruiting NCT00294476 - IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma Phase 2
Completed NCT03602079 - Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene Phase 1/Phase 2
Recruiting NCT05725304 - The Registry of Genetic Expression of Taiwan Urologic Cancer
Not yet recruiting NCT05920343 - VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy Phase 2/Phase 3
Completed NCT03245788 - Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study N/A
Recruiting NCT04702347 - Genetic Testing in Upper Tract Urothelial Carcinoma (UTUC): the Epicheck Study